Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study

Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis

Introduction: Heterosexual men are not considered a key population in the HIV response

Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study

Epidemiological impact and cost‐effectiveness of providing long‐acting pre‐exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study

Abstract Introduction Although pre‐exposure prophylaxis (PrEP.) is an efficacious HIV prevention

Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis

Introduction Women in sub-Saharan Africa (SSA) experience the world's highest rates of both HIV inf

LENACAPAVIR FOR HIV PRE-EXPOSURE PROPHYLAXIS IN SUB-SAHARAN AFRICA: A Scoping Review of Health System Readiness and Implementation Barriers

The primary research question, structured using the PICO framework, was: Among HIV-negative individu

Optimising scale-up of injectable lenacapavir for HIV pre-exposure prophylaxis in South Africa: A modelling study and economic evaluation

Background South Africa accounts for 20% of global HIV infections. Six-monthly